Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002388186 | SCV002697196 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-04-28 | criteria provided, single submitter | clinical testing | The p.L488P variant (also known as c.1463T>C), located in coding exon 11 of the APC gene, results from a T to C substitution at nucleotide position 1463. The leucine at codon 488 is replaced by proline, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
3DMed Clinical Laboratory Inc | RCV000677774 | SCV000803930 | uncertain significance | Colon adenocarcinoma | 2018-01-18 | no assertion criteria provided | clinical testing |